Literature DB >> 12097600

Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure.

Amalio Telenti1, Raquel Martinez, Miguel Munoz, Gabriela Bleiber, Gilbert Greub, Dominique Sanglard, Solange Peters.   

Abstract

Human immunodeficiency virus type 1 uses ribosomal frameshifting for translation of the Gag-Pol polyprotein. Frameshift activities are thought to be tightly regulated. Analysis of gag p1 sequences from 270 plasma virions identified in 64% of the samples the occurrence of polymorphism that could lead to changes in thermodynamic stability of the stem-loop. Expression in Saccharomyces cerevisiae of p1-beta-galactosidase fusion proteins from 10 representative natural stem-loop variants and three laboratory mutant constructs (predicted the thermodynamic stability [Delta G degrees] ranging from -23.0 to -4.3 kcal/mol) identified a reduction in frameshift activity of 13 to 67% compared with constructs with the wild-type stem-loop (Delta G degrees, -23.5 kcal/mol). Viruses carrying stem-loops associated with greater than 60% reductions in frameshift activity presented profound defects in viral replication. In contrast, viruses with stem-loop structures associated with 16 to 42% reductions in frameshift efficiency displayed no significant viral replication deficit.

Entities:  

Mesh:

Year:  2002        PMID: 12097600      PMCID: PMC136395          DOI: 10.1128/jvi.76.15.7868-7873.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.

Authors:  F Bally; R Martinez; S Peters; P Sudre; A Telenti
Journal:  AIDS Res Hum Retroviruses       Date:  2000-09-01       Impact factor: 2.205

2.  Improved method for high efficiency transformation of intact yeast cells.

Authors:  D Gietz; A St Jean; R A Woods; R H Schiestl
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

3.  Ribosomal frameshifting efficiency and gag/gag-pol ratio are critical for yeast M1 double-stranded RNA virus propagation.

Authors:  J D Dinman; R B Wickner
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.

Authors:  G Bleiber; M Munoz; A Ciuffi; P Meylan; A Telenti
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing.

Authors:  K M Felsenstein; S P Goff
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells.

Authors:  H Reil; H Kollmus; U H Weidle; H Hauser
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein.

Authors:  C Paulus; S Hellebrand; U Tessmer; H Wolf; H G Kräusslich; R Wagner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

8.  Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.

Authors:  V Karacostas; E J Wolffe; K Nagashima; M A Gonda; B Moss
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

9.  Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo.

Authors:  N T Parkin; M Chamorro; H E Varmus
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more
  31 in total

Review 1.  Targeting frameshifting in the human immunodeficiency virus.

Authors:  Léa Brakier-Gingras; Johanie Charbonneau; Samuel E Butcher
Journal:  Expert Opin Ther Targets       Date:  2012-03       Impact factor: 6.902

2.  Translational recoding signals between gag and pol in diverse LTR retrotransposons.

Authors:  Xiang Gao; Ericka R Havecker; Pavel V Baranov; John F Atkins; Daniel F Voytas
Journal:  RNA       Date:  2003-12       Impact factor: 4.942

3.  Solution structure of the HIV-1 frameshift inducing stem-loop RNA.

Authors:  David W Staple; Samuel E Butcher
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

4.  Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M.

Authors:  Martin Baril; Dominic Dulude; Karine Gendron; Guy Lemay; Léa Brakier-Gingras
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

5.  Mutational patterns in the frameshift-regulating site of HIV-1 selected by protease inhibitors.

Authors:  Elena Knops; Léa Brakier-Gingras; Eugen Schülter; Herbert Pfister; Rolf Kaiser; Jens Verheyen
Journal:  Med Microbiol Immunol       Date:  2011-12-27       Impact factor: 3.402

6.  Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.

Authors:  Prakash B Palde; Leslie O Ofori; Peter C Gareiss; Jaclyn Lerea; Benjamin L Miller
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

7.  Identification of a cellular factor that modulates HIV-1 programmed ribosomal frameshifting.

Authors:  Yoshifumi Kobayashi; Jianling Zhuang; Stuart Peltz; Joseph Dougherty
Journal:  J Biol Chem       Date:  2010-04-23       Impact factor: 5.157

8.  Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients.

Authors:  Lucile Larrouy; C Chazallon; R Landman; C Capitant; G Peytavin; G Collin; C Charpentier; A Storto; G Pialoux; C Katlama; P M Girard; P Yeni; J P Aboulker; F Brun-Vezinet; D Descamps
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

9.  Achieving a golden mean: mechanisms by which coronaviruses ensure synthesis of the correct stoichiometric ratios of viral proteins.

Authors:  Ewan P Plant; Rasa Rakauskaite; Deborah R Taylor; Jonathan D Dinman
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

10.  Characterization of RNA elements that regulate gag-pol ribosomal frameshifting in equine infectious anemia virus.

Authors:  Chaoping Chen; Ronald C Montelaro
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.